The high and correlated expression of CA12 and TFF3 in estrogen receptor-positive BC may play a role in reducing the tumor’s sensitivity to chemotherapy drugs such as adriamycin and docetaxel, which in turn can negatively impact the efficacy of NAC [26]. This evidence concerns the gene TFF3 and neoplasm.